适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- ROCHE
- 入组人数
- 20
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 18 and 70 years.
- •2. Established diagnosis of systemic sclerosis according to ARA-criteria (appendix).
排除标准
- •1. Pregnancy or unwillingness to use adequate contraception during study.
- •2. Previous treatments with biological agents, cell depleting therapies including investigational
研究者
相似试验
已完成
2 期
Rituximab in Systemic SclerosisSystemic SclerosisNCT01748084Assistance Publique - Hôpitaux de Paris22
已完成
1 期
Rituximab in the Treatment of Scleritis and Non-Infectious Orbital InflammationScleritisOrbital DiseaseNCT00415506Oregon Health and Science University20
已完成
不适用
Efficacy of rituximab in patients with systemic sclerosisSystemic sclerosis (SSc)Skin and Connective Tissue DiseasesSystemic sclerosisISRCTN99672071niversity Hospital of Patras (Greece)15
进行中（未招募）
1 期
Study the action of a single dose of intrathecally-infused rituximab upon cerebro-spinal fluid (CSF) biological targets, assuming that a definitive action upon CSF biological targets would be strongly predictive of a delayed clinical action in patients with Progressive Multiple Sclerosis.EUCTR2014-005493-11-FRCentre Hospitalier de Pau12
进行中（未招募）
不适用
se of Rituximab in the treatment of extensive chronic graft versus host disease after allogenic stem cells transplantatioEUCTR2004-004819-29-ITIVERSITA' DEGLI STUDI DI UDINE20